Shares of Precision BioSciences DTIL rallied 23.8% on Tuesday after the company’s announcement that the FDA has granted Fast ...

Famciclovir. A prodrug of penciclovir, famciclovir does not have a major role in the treatment of chronic hepatitis B because of its low efficacy compared with lamivudine. Adefovir dipivoxil.

The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an investigational gene editing therapy for adults with chronic hepatitis B.

The main goals of chronic hepatitis B treatment should be the long-term suppression of viral replication to minimize disease progression and the risk for the development of hepatocellular carcinoma.

Researchers are now exploring strategies to silence cccDNA, aiming for a functional cure and offering hope to millions of patients worldwide. Hepatitis B virus infection remains one of the leading ...

Catching HBV early can make a world of difference. Medical professionals typically use blood tests that check for signs of the virus in the body, such as HBV antigens or antibodies. They also ...

In April 2025, Vir Biotechnology Inc. announced a phase 1b/2 platform study framework to evaluate the safety and efficacy of ...

Current treatments for CHB primarily aim to suppress HBV. However, researchers are working toward improving rates of “functional cure” which is achieved when levels of hepatitis B surface ...

An in-depth look at Hepatitis D, why it’s so severe, and how new therapies bring hope for better treatment and prevention.

People fully vaccinated against hepatitis B who are not immunocompromised can expect sustained immunity throughout their ...

The following is a summary of “Chronic hepatitis B virus infection increases the risk of kidney disease while antiviral ...